DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO. Stock

Certificat

DE000ME7KNX8

Market Closed - Börse Stuttgart 14:46:26 2024-06-07 EDT
164.4 EUR +0.69% Intraday chart for DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO.
Current month+0.69%
1 month+0.11%
Date Price Change
24-06-07 164.4 +0.69%
24-06-06 163.3 -0.06%
24-06-05 163.4 +0.15%
24-06-04 163.1 +0.14%
24-06-03 162.9 -0.23%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 02:46 pm

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME7KNX
ISINDE000ME7KNX8
Date issued 2024-01-25
Maturity 2024-09-20 (104 Days)
Parity 1 : 1
Emission price 162.2
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 165.2
Lowest since issue 158.1
Spread 0.08
Spread %0.05%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
240.6 USD
Average target price
278.7 USD
Spread / Average Target
+15.81%
Consensus